For research use only. Not for therapeutic Use.
PD153035 HCl (Cat No.: I002379) is a highly potent and specific inhibitor of the Epidermal Growth Factor Receptor (EGFR). Its remarkable binding affinity is reflected in its Ki (inhibition constant) of 5.2 pM and an IC50 (half-maximal inhibitory concentration) of 29 pM. PD153035 HCl demonstrates exceptional selectivity for EGFR, with minimal impact on other receptor kinases, including PGDFR, FGFR, CSF-1, InsR, and Src. This makes it a valuable tool for researchers studying EGFR-related signaling pathways and potential therapeutic interventions targeting EGFR-driven diseases, particularly in the field of oncology. If you need to, please contact us in time, and we will reply to you as soon as possible within 24 hours.
Catalog Number | I002379 |
CAS Number | 183322-45-4 |
Synonyms | AG-1517 |
Molecular Formula | C16H14BrN3O2 • HCl |
Purity | ≥95% |
Target | EGFR |
Solubility | DMSO <1.2mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL |
Storage | Room Temperature |
IC50 | 5.2/29 pM(Ki/IC50) [1] |
IUPAC Name | N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;hydrochloride |
InChI | InChI=1S/C16H14BrN3O2.ClH/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11;/h3-9H,1-2H3,(H,18,19,20);1H |
InChIKey | ZJOKWAWPAPMNIM-UHFFFAOYSA-N |
SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OC.Cl |
Reference | <p style=/line-height:25px/> |